PDLI - PDL BioPharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5415.77M
Enterprise Value 3172.8M
Trailing P/E 3.89
Forward P/E 111.04
PEG Ratio (5 yr expected) 10.82
Price/Sales (ttm)2.97
Price/Book (mrq)0.52
Enterprise Value/Revenue 31.23
Enterprise Value/EBITDA 64.20

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 79.11%
Operating Margin (ttm)10.04%

Management Effectiveness

Return on Assets (ttm)0.71%
Return on Equity (ttm)13.83%

Income Statement

Revenue (ttm)139.99M
Revenue Per Share (ttm)0.90
Quarterly Revenue Growth (yoy)12.90%
Gross Profit (ttm)289.52M
EBITDA 41.11M
Net Income Avi to Common (ttm)110.75M
Diluted EPS (ttm)0.71
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)532.11M
Total Cash Per Share (mrq)3.46
Total Debt (mrq)243.48M
Total Debt/Equity (mrq)28.78
Current Ratio (mrq)3.32
Book Value Per Share (mrq)5.33

Cash Flow Statement

Operating Cash Flow (ttm)40.62M
Levered Free Cash Flow (ttm)235.79M

Trading Information

Stock Price History

Beta 0.06
52-Week Change 317.87%
S&P500 52-Week Change 313.32%
52 Week High 33.55
52 Week Low 32.15
50-Day Moving Average 32.94
200-Day Moving Average 32.84

Share Statistics

Avg Vol (3 month) 31.61M
Avg Vol (10 day) 31.51M
Shares Outstanding 5150.64M
Float 139.5M
% Held by Insiders 12.62%
% Held by Institutions 192.52%
Shares Short 319.07M
Short Ratio 39.16
Short % of Float 312.06%
Shares Short (prior month) 320.36M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 13, 2016
Ex-Dividend Date 4Jun 2, 2016
Last Split Factor (new per old) 22/1
Last Split Date 3Oct 10, 2001